CNS cancer - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals

Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates

Vikran Engineering (NSE: VIKRAN) Q3 FY26 results show solar-led order book surge as margins reset during execution ramp-up

Ducon Infratechnologies (NSE: DUCON) Q3 FY26 results signal margin pressure even as carbon capture and AI bets move closer to execution

Read More

5 minute read

Pharma Industry News

Plus Therapeutics wins major reimbursement milestone as Humana approves CNSide cerebrospinal fluid assay

Find out how Plus Therapeutics secured Humana’s national coverage for the CNSide assay and what it means for metastatic CNS cancer care today.

bySoujanya Ravi

November 20, 2025

web analytics